Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026
Same author

AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes.

Blood advances·2026
Same author

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

Cancer imaging : the official publication of the International Cancer Imaging Society·2026
Same author

Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?

European journal of nuclear medicine and molecular imaging·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: margin assessment.

The Lancet. Oncology·2026
Same author

International multisociety Delphi consensus for liver tumour thermal ablation: procedural and practice standards.

The Lancet. Oncology·2026

Related Experiment Video

Updated: Sep 4, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K

Virtual Biopsy in Soft Tissue Sarcoma. How Close Are We?

Amani Arthur1, Edward W Johnston2, Jessica M Winfield1,2

  • 1Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, United Kingdom.

Frontiers in Oncology
|July 18, 2022
PubMed
Summary

Imaging biomarkers and computational science enable "virtual biopsies" for oncology, offering new insights into soft tissue sarcoma (STS) heterogeneity and personalized treatment. This data-driven approach promises to revolutionize cancer management and improve patient outcomes.

Keywords:
MRIimaging biomarkerquantitative MRI (qMRI)radiology pathology correlationradiomicssarcomasoft tissue sarcoma (STS)virtual biopsy

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.4K
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
09:17

Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy

Published on: May 3, 2019

7.5K

Related Experiment Videos

Last Updated: Sep 4, 2025

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.4K
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
09:17

Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy

Published on: May 3, 2019

7.5K

Area of Science:

  • Radiology and oncology
  • Computational science and biomedical imaging

Background:

  • Radiology is shifting towards a data-driven specialty, leveraging advancements in imaging biomarkers (IB) and computational science.
  • The development of
  • virtual biopsies
  • aims to non-invasively probe tumor biology spatially and temporally, enhancing the management of complex cancers.
  • Soft tissue sarcomas (STS) present significant treatment challenges due to their rarity, over 150 histological subtypes, and pronounced inter- and intra-tumoral heterogeneity.

Purpose of the Study:

  • To provide an overview of imaging biomarker (IB) development for soft tissue sarcomas (STS).
  • To highlight key advancements in imaging and computational science relevant to STS.
  • To discuss the potential of virtual biopsies to revolutionize STS management.

Main Methods:

  • Overview of successful IB development processes.
  • Review of quantitative magnetic resonance imaging, radiomics, and artificial intelligence in STS.
  • Exploration of studies correlating imaging metrics with biological surrogates.

Main Results:

  • Synergistic developments in imaging biomarkers and computational science are enabling virtual biopsies in oncology.
  • Quantitative imaging, radiomics, and AI show promise in characterizing STS heterogeneity.
  • Studies are exploring biological surrogates for imaging metrics in STS.

Conclusions:

  • Virtual biopsies have the potential to significantly improve diagnostic accuracy and personalized treatment planning for STS.
  • Routine clinical implementation of virtual biopsies could revolutionize the management of complex cancers like STS.
  • Further research into IB development and computational methods will enhance clinical outcomes for STS patients.